P
Peptilogics
Biotech & Life Sciences · Pittsburgh, United States · Founded 2013
A biotech company developing a breakthrough technology platform in the antimicrobial segment MoreLess
Peptilogics is a clinical-stage biotechnology company focused on transforming the discovery and development of novel peptide therapeutics. The company leverages the untapped potential of peptide biology combined with the power of machine learning to scale its drug design approach. Peptilogics aims to usher in the next generation of peptide therapeutics through precision engineering and design. Its lead therapeutic, PLG0206, is a novel, broad-spectrum anti-infective currently under clinical investigation for the treatment of prosthetic joint infection, a condition with significant unmet medical needs. The company primarily serves patients with serious and life-threatening diseases, operating within the biotechnology and pharmaceutical markets. Peptilogics generates revenue through the development and potential commercialization of its peptide-based drugs. Keywords: peptide therapeutics, machine learning, drug design, clinical-stage, biotechnology, anti-infective, prosthetic joint infection, precision engineering, peptide biology, pharmaceutical.
Company overview
Peptilogics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- Pittsburgh, United States
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 85.6
Valuation & funding
Peptilogics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2025 | $78M | $312M | AMR Action Fund · Beyond Ventures · Presight Capital · Thiel Bio | ↗ |
| GRANTOther financing | Jan 2025 | $3.3M | — | CARB-X | ↗ |
| GRANTOther financing | Jan 2022 | $0 | — | Cystic Fibrosis Foundation | — |
| SERIES BOther financing | Dec 2020 | $35M | $142M | Founders Fund · Peter Thiel · Presight Capital | — |
| GRANTOther financing | Feb 2020 | $2.6M | — | CARB-X | — |
| EARLY VCOther financing | Jun 2019 | Innovation Works | — | ||
| SERIES AOther financing | Sep 2017 | Peter Thiel · BlueTree Venture Fund · Stefan Roever | — | ||
| SEEDOther financing | Oct 2016 | BlueTree Allied Angels · Pittsburgh Life Sciences Greenhouse · Idea Foundry | — | ||
| SEEDOther financing | Jan 2016 | Undisclosed | — | ||
| CONVERTIBLEOther financing | Sep 2013 | Undisclosed | — |
Growth signals
Peptilogics website traffic
Latest recorded traffic for Peptilogics is 4.1K monthly website visits, down 4.7% over the last three months. Peptilogics's team grew 10% over the past year.
Hiring
Open positions at Peptilogics
Current openings linked to this company in Dealroom.
Comparisons
Peptilogics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Peptilogics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Peptilogics has talent and traffic
team presence
In the news
Latest news about Peptilogics
Recent press, funding announcements, and product moves mentioning Peptilogics — open to read from the original sources.
Market sentiment
What the market is saying about Peptilogics
An AI-synthesized read of the highest-engagement posts about Peptilogics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Peptilogics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.